Skip to content

Hyperbaric Oxygen and Manipulative Therapies to Regain Function Post Stroke

Oxygenating the Potential: Hyperbaric Oxygen and Manipulative Therapies to Regain Function in Stroke Survivors

Status
Completed
Phases
Early Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03352232
Acronym
HBOT/OMT
Enrollment
5
Registered
2017-11-24
Start date
2018-02-03
Completion date
2021-07-19
Last updated
2021-12-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Stroke, Ischemic Stroke, Motor Dysfunction, Stroke

Brief summary

To study safety, feasibility and outcomes of combining osteopathic manipulative therapies with hyperbaric oxygen therapy in reducing the functional deficits in stroke survivors in subacute and chronic phases post ischemic stroke. To document the same as part of a pilot project in anticipation of further investigational studies.

Detailed description

The primary objective of this study is to show that hyperbaric oxygen therapy combined with osteopathic manipulative therapies improve outcomes in patients who have persistent neurological deficits after ischemic stroke compared to historical norms. The secondary objectives of this study is to demonstrate safety and feasibility of treating patients post stroke with hyperbaric oxygen and osteopathic therapies as well as determine improvements in multiple assessment scales of motor function, depression, activities of daily living(ADL) and pain

Interventions

COMBINATION_PRODUCTHBOT and OMT

Hyperbaric oxygen therapy (HBOT) is defined as breathing 100% oxygen at increased atmospheric pressure. Osteopathic manipulative therapy (OMT) is used for myriad ailments including contractures, pain, spasticity. Patients in intervention arms will receive hyperbaric oxygen therapy at 2ATM (atmospheres) for 90minutes daily for up to 6weeks. In addition, they will receive osteopathic manipulative therapies twice a week during the same treatment phase.

Sponsors

Philadelphia College of Osteopathic Medicine
CollaboratorOTHER
Abington Memorial Hospital
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

There will be two populations based on when they experienced a stroke. Subacute stroke patients will have suffered an ischemic stroke within 3 months of enrollment and have persistent neurological deficits. The second group will be patients who suffered an ischemic stroke more than 6 months (chronic) from time of enrollment and have persistent neurological deficits compromising activities of daily living.

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

1. Post Ischemic stroke 2. Patients aged 18-80 3. NIHSS \>5 4. mRS\>/=3, which connotes moderate disability requiring some help. 5. Persistent significant motor dysfunction of at least one arm 6. Subacute stroke patients (within three months from time of stroke) 7. Chronic stroke patients (more than 6months from time of stroke) 8. Patient must be able to understand instructions and verbalize discomfort 9. Reliable attendance for daily (M-F) HBOT treatment and 2x/week OMT sessions for up to 6weeks

Exclusion criteria

1. Hemorrhagic stroke 2. Prior functional disability mRS \>1 3. Expressive or receptive aphasia 4. Bedbound patients due to lifting limitations for HBOT 5. History of severe, advanced emphysema with bullous disease 6. Prior history of spontaneous pneumothorax or chest surgery 7. Prior history of depression requiring medications 8. Pregnancy 9. Concomitant non-conventional rehab therapies including: acupuncture, botulinum toxin injections, massage therapy 10. Significant claustrophobia

Design outcomes

Primary

MeasureTime frameDescription
National Institute of Health Stroke Score (NIHSS) 0-5 or Modified Rankin Score (mRS) 0-290 DaysPrimary Outcome NIHSS 0-5, 0 without deficits; mRS 0-2, 0 without disability - 2 slight disability, no need for assistance

Secondary

MeasureTime frameDescription
Beck Depression Inventory90 daysassessment of Depression scale rating
Wolf Motor Score90 daysassessment of functional motor recovery
Rivermead Extended Activities of Daily Living (EADL) scale90 daysassessment of capability navigating usual and community based ADLs
Medical Outcomes 36 Item90 daysassessment of global health
Functional Independence Measure (FIM)90 daysuniversally used assessment of patient's ability to perform activities of daily living

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026